Bank of New York Mellon Corp acquired a new position in Herbalife Ltd (NYSE:HLF - Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 444,280 shares of the company's stock, valued at approximately $5,842,000. Bank of New York Mellon Corp owned approximately 0.43% of Herbalife at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in HLF. Pacer Advisors Inc. acquired a new position in shares of Herbalife during the first quarter valued at $9,491,000. Manatuck Hill Partners LLC lifted its holdings in Herbalife by 122.2% in the third quarter. Manatuck Hill Partners LLC now owns 1,000,000 shares of the company's stock worth $8,440,000 after purchasing an additional 550,000 shares during the period. Dimensional Fund Advisors LP grew its position in Herbalife by 29.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,877,717 shares of the company's stock valued at $27,638,000 after buying an additional 425,968 shares in the last quarter. Johnson Financial Group LLC increased its stake in Herbalife by 1,156.1% during the 4th quarter. Johnson Financial Group LLC now owns 414,500 shares of the company's stock valued at $5,343,000 after buying an additional 381,500 shares during the period. Finally, Invenomic Capital Management LP increased its stake in Herbalife by 82.6% during the 4th quarter. Invenomic Capital Management LP now owns 768,031 shares of the company's stock valued at $9,900,000 after buying an additional 347,401 shares during the period.
Analysts Set New Price Targets
HLF has been the topic of a number of research analyst reports. Citigroup reaffirmed a "buy" rating and set a $17.00 target price (down from $21.00) on shares of Herbalife in a report on Friday, August 7th. Weiss Ratings lowered Herbalife from a "hold (c+)" rating to a "hold (c)" rating in a report on Friday, July 24th. Finally, Wall Street Zen lowered shares of Herbalife from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. Three research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, Herbalife currently has a consensus rating of "Hold" and a consensus target price of $17.00.
Read Our Latest Report on HLF
Herbalife Trading Up 1.8%
Shares of Herbalife stock opened at $12.39 on Friday. The firm has a fifty day simple moving average of $12.39 and a 200-day simple moving average of $13.87. The stock has a market capitalization of $1.30 billion, a price-to-earnings ratio of 7.99, a PEG ratio of 0.40 and a beta of 0.85. Herbalife Ltd has a 1-year low of $7.56 and a 1-year high of $20.40.
Herbalife (NYSE:HLF - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.51 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.54 by ($0.03). The firm had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.31 billion. Herbalife had a net margin of 3.16% and a negative return on equity of 43.90%. The business's quarterly revenue was up 5.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.59 earnings per share. As a group, research analysts predict that Herbalife Ltd will post 2.68 earnings per share for the current year.
Herbalife Company Profile
(
Free Report)
Herbalife Nutrition Ltd. NYSE: HLF operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.
Founded in 1980 by Mark R.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.